Navigation Links
Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
Date:5/7/2012

HealthCare, to be cancelled or terminated, and risks associated with third party intellectual property and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2011 and Form 10-Q for the quarter ended March 31, 2012. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.Contacts Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914.847.7799

914.847.764michael.aberman@regeneron.com

peter.dworkin@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
2. Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody
3. Regeneron Announces February 2012 Investor Conference Presentations
4. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
5. Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
6. Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
7. Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
8. Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
9. Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
10. Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
11. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Salix Pharmaceuticals, Ltd. (the " Company " ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... Fundamental Changes, Make-Whole Fundamental Changes and Merger Event, Fundamental ... and Offer to Purchase (the " Notice ") to ... (the " Notes "), pursuant to the Indenture, dated ...
(Date:4/1/2015)... , April 1, 2015  Hologic, Inc. (NASDAQ: ... holders of the 2.00% Convertible Exchange Senior Notes due ... and Wilmington Trust Company, the trustee, paying agent and ... to convert the notes.  This conversion right is subject ... notes dated as of December 10, 2007, as supplemented ...
(Date:4/1/2015)... ATLANTA , April 1, 2015  The ... medication, and dietary supplements to treat attention-deficit/hyperactivity disorder ... than one half of children with ADHD were ... Centers for Disease Control and Prevention (CDC) study, ... Health Care Needs," published today in The ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... IRIDEX Corporation (Nasdaq: IRIX ) today announced ... the ROTH 23rd Annual OC Growth Stock Conference on Monday, ... being held March 13-16 at the Ritz Carlton Laguna Niguel ... accessible by live webcast on the Investor section of IRIDEX,s ...
... 2011 To help reduce state Medicaid spending, the ... in charge of the state,s Medicaid program, has proposed ... like those in the private sector that are more ... would save state taxpayers $82 million.  Governors Chris Christie ...
Cached Medicine Technology:Texas Health and Human Services Commission: Modernize Medicaid Pharmacy to Save State $82 Million 2
(Date:4/2/2015)... 2015 Veale Outdoor Advertising, the Northern ... billboards to its name, announces its digital display in ... area. Similar to the first 14-by-48 foot digital ... California, the addition means, in total, the Network reaches ... after tourist population traveling through the San Francisco, Sonoma, ...
(Date:4/2/2015)... (PRWEB) April 02, 2015 Steviva ... and custom sweetening solutions, recently announced the rebranding ... are Erysweet+ with stevia and Erysweet+ 100 mesh ... Stevia Blend fine powder, respectively. , Erysweet+ with ... and naturally fermented erythritol. It delivers a natural ...
(Date:4/2/2015)... Atlanta-based Kanga, the first SaaS-based platform for management ... Up in Atlanta by General Assembly Atlanta. Six companies ... LOV, Ticket Alternative, and TripTap. T General Assembly presented ... 500 at their Atlanta Launch Party at Ponce City ... platform for initiating, managing and tracking last mile deliveries ...
(Date:4/1/2015)... (PRWEB) April 02, 2015 Robins & ... Southern Living Media Services Building for the New T-Mobile ... just five months, including complete demolition of the interior ... the addition of 250 parking spaces to accommodate employees. ... says his firm was excited to develop such a ...
(Date:4/1/2015)... 2015 Glen Mills, PA - Holganix ... Farm’s, Healthy Grow fertilizer line to produce an organic-based ... Holganix manufactures a line of organic bionutritional products that ... optimal plant, turf and tree health. Pearl Valley Farms ... and a manufacturer of organic fertilizers. , Healthy ...
Breaking Medicine News(10 mins):Health News:Veale Outdoor Advertising State of the Art Digital Billboards Reach 12 Million in SF Bay Area 2Health News:Steviva Ingredients Announces Erysweet+ Rebrand 2Health News:Kanga Wins Best Start Up in Atlanta 2Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:Holganix Expands Its Organic Turf Portfolio Success by Partnering with Pearl Valley Farms to Produce an Organic-Based Granular Fertilizer 2
... about the fifty states--from Spanish speakers to strawberries produced to Bigfoot ... ... Washington, DC (PRWEB) February 4, 2009 -- SHOW®USA, a website with ... the fifty states in a whole new way, launched today. , ...
... The economic cost of methamphetamine use in the United ... of addiction, premature death, drug treatment and many other ... Corporation study. , The RAND study is the first ... costs of the methamphetamine problem in the United States. ...
... Previously Issued Recall to Wholesale Level on Certain Products Expanded ... subsidiary of KV Pharmaceutical Company (NYSE: KVa ... level of a previously announced recall on certain products. ... issued to the wholesale level, but is now being expanded ...
... Feb. 3 Companies that manufacture products containing ... product stewardship measures to limit potential liability exposure ... Klapper and James Wood.This issue will be thoroughly ... Law, Regulation and Policy, February 18-19, 2009, in ...
... involved in cell migration, is associated with liver cancer ... be used as a biomarker for diagnosis and a ... issue of Hepatology , a journal published by ... Association for the Study of Liver Diseases (AASLD). The ...
... lives of one million families by offering an economic ... Shaklee Corporation Chairman and CEO Roger Barnett will ... offers economic support to one million families in 2009. ... Greensboro, NC. "Families are struggling to make ends ...
Cached Medicine News:Health News:SHOWUSA Launches: New Website Showcases Animated Maps of U.S. Facts and Figures 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 3Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:Risk-Management Policies Needed Now in Nanotechnology, Insighter Piece Concludes; FDLI Sponsors Nanotechnology Meeting, Publishes Book on FDA-Regulated Products 2Health News:Protein predicts liver cancer recurrence and after transplantation 2Health News:Shaklee Hits the Road With Its Infinite Possibilities Tour 2
... kit features a patented Per-fit™ flexible PVC ... a low-profile cuff specifically designed to reduce ... the patients anatomy. The kit s unique ... tube snugly, allowing for an easier transition ...
... Self-contained kits provide convenience and cost control. ... care trays offer a variety of wound ... management of the tracheostomized patient. , ... and trays with disposable inner cannula for ...
Disposable tracheostomy care tray....
... Medline Has the Right Solution For ... tracheostomy clean and care tray features the ... of this important infection control task. Designed ... the individual needs of each patient and ...
Medicine Products: